An evaluation based on relative treatment intensity in older patients treated with reduced-dose R-THP-COP therapy for diffuse large B-cell lymphoma: A multicenter retrospective cohort study.

Takayuki Hiroi,Hiroki Hosoi,Kodai Kuriyama,Shogo Murata,Masaya Morimoto,Toshiki Mushino,Akinori Nishikawa,Shinobu Tamura,Takashi Sonoki

Journal of geriatric oncology（2023）

引用 0|浏览5

暂无评分

摘要

Our study suggests that the reduced-dose R-THP-COP regimen is a suitable treatment option for older patients with DLBCL, especially those with CCI scores of <2. Our study also showed that the RTI may be a valuable tool for assessing treatment intensity in retrospective studies involving older patients.

查看译文

关键词

Comorbidity,Diffuse large B-cell lymphoma,Dose intensity,Older patients,Pirarubicin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要